Koga T, Chaim I, Benitez J, Markmiller S, Parisian A, Hevner R, et al. Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells. Nat Commun. 2020;11:550 pubmed publisher

Johnson Chacko L, Pechriggl E, Fritsch H, Rask Andersen H, Blumer M, Schrott Fischer A, et al. Neurosensory Differentiation and Innervation Patterning in the Human Fetal Vestibular End Organs between the Gestational Weeks 8-12. Front Neuroanat. 2016;10:111 pubmed

Cidado J, Wong H, Rosen D, Cimino Mathews A, Garay J, Fessler A, et al. Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget. 2016;7:6281-93 pubmed publisher

Fusco N, Guerini Rocco E, Del Gobbo A, Franco R, Zito Marino F, Vaira V, et al. The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations. PLoS ONE. 2015;10:e0144923 pubmed publisher

Maris P, Blomme A, Palacios A, Costanza B, Bellahcène A, Bianchi E, et al. Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Med. 2015;12:e1001871 pubmed publisher

Maqdasy S, Bogenmann L, Batisse Lignier M, Roche B, Franck F, Desbiez F, et al. Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature. Reprod Biol Endocrinol. 2015;13:72 pubmed publisher

Zandvakili I, Davis A, Hu G, Zheng Y. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice. PLoS ONE. 2015;10:e0127923 pubmed publisher

Magnussen S, Rikardsen O, Hadler Olsen E, Uhlin Hansen L, Steigen S, Svineng G. Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC). PLoS ONE. 2014;9:e101895 pubmed publisher

Abubaker K, Luwor R, Escalona R, McNally O, Quinn M, Thompson E, et al. Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden. Front Oncol. 2014;4:75 pubmed publisher

Amann A, Zwierzina M, Gamerith G, Bitsche M, Huber J, Vogel G, et al. Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells. PLoS ONE. 2014;9:e92511 pubmed publisher

Borodovsky A, Salmasi V, Turcan S, Fabius A, Baia G, Eberhart C, et al. 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget. 2013;4:1737-47 pubmed

Sorbye S, Kilvaer T, Valkov A, Donnem T, Smeland E, Al Shibli K, et al. Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas. PLoS ONE. 2012;7:e47068 pubmed publisher

Belton A, Gabrovsky A, Bae Y, Reeves R, Iacobuzio Donahue C, Huso D, et al. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS ONE. 2012;7:e30034 pubmed publisher

Palmer R, Vernersson E, Grabbe C, Hallberg B. Anaplastic lymphoma kinase: signalling in development and disease. Biochem J. 2009;420:345-61 pubmed publisher